Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

352.00p
   
  • Change Today:
    -1.00p
  • 52 Week High: 445.00p
  • 52 Week Low: 232.50p
  • Currency: UK Pounds
  • Shares Issued: 106.14m
  • Volume: 200,824
  • Market Cap: £373.60m
  • RiskGrade: 125
  • Beta: 0.00

Oxford Biomedica signs new Covid vaccine deal with AstraZeneca

By Frank Prenesti

Date: Friday 01 Jul 2022

LONDON (ShareCast) - (Sharecast News) - Oxford Biomedica has signed a new three-year deal to make AstraZeneca's Covid-19 vaccine beyond this year when the original agreement expires, the company said on Friday.
The Oxford-based gene and cell therapy group said it expected to record about £30m in revenue from the contract in the current financial year.

Under the new deal, manufacturing of vaccines at Oxford manufacturing facility, Oxbox, will be available to AstraZeneca on an as-needed basis beyond 2022.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 352.00p
Change Today -1.00p
% Change -0.28 %
52 Week High 445.00p
52 Week Low 232.50p
Volume 200,824
Shares Issued 106.14m
Market Cap £373.60m
Beta 0.00
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
31.62% below the market average31.62% below the market average31.62% below the market average31.62% below the market average31.62% below the market average
13.04% above the sector average13.04% above the sector average13.04% above the sector average13.04% above the sector average13.04% above the sector average
Price Trend
32.31% below the market average32.31% below the market average32.31% below the market average32.31% below the market average32.31% below the market average
17.39% above the sector average17.39% above the sector average17.39% above the sector average17.39% above the sector average17.39% above the sector average
Income Not Available
Growth
2.91% above the market average2.91% above the market average2.91% above the market average2.91% above the market average2.91% above the market average
12.5% below the sector average12.5% below the sector average12.5% below the sector average12.5% below the sector average12.5% below the sector average

What The Brokers Say

Strong Buy 3
Buy 2
Neutral 4
Sell 0
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 11-Jul-2025

Time Volume / Share Price
15:20 141 @ 354.00p
16:35 36,237 @ 352.00p
16:35 95 @ 352.00p
16:35 191 @ 352.00p
16:35 303 @ 352.00p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page